Filing Flows › Procept BioRobotics (PRCT) › R&D spending
Procept BioRobotics (PRCT) R&D spending by quarter
Procept BioRobotics' R&D spending was $20.0M in Q3 2026 (third quarter 2026), -0.4% from Q2 2026. Over the last 7 quarters it ranged from $16.4M (Q1 2025) to $21.5M (Q1 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $20.0M | -0.4% | +10% |
| Q2 2026 | $20.1M | -6% | +14% |
| Q1 2026 | $21.5M | +13% | +31% |
| Q4 2025 | $19.1M | +5% | — |
| Q3 2025 | $18.2M | +3% | — |
| Q2 2025 | $17.6M | +7% | — |
| Q1 2025 | $16.4M | — | — |
Q3 2026 at a glance
Procept BioRobotics, Q3 2026: revenue $98.3M (+18% year over year), operating margin -27.9%, net loss $26.5M, operating cash flow −$9.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Procept BioRobotics' R&D spending?
Procept BioRobotics' R&D spending was $20.0M in Q3 2026 (third quarter 2026), -0.4% from Q2 2026.
How has Procept BioRobotics' R&D spending changed?
Over the last 7 quarters it ranged from $16.4M (Q1 2025) to $21.5M (Q1 2026).